FMED ETF (Fidelity Disruptive Medicine ETF) is managed by Fidelity Investments (US) with $62.2M in net assets. FMED expense ratio is 0.50%, holding 75 positions across sectors including Health Care, Unknown, Other. Inception date: 2023-02-13.

FMED performance shows a YTD return of -2.61%. The 1-year return is 4.01%.

FMED top holdings include Net Other Assets (6.0%), Fidelity Securities Lending Cash Central Fund (6.0%), Boston Scientific Corp (4.5%), Argenx Se Spon Adr Each Rep 1 Ord Shs (4.1%), Alnylam Pharmace (3.8%). View all FMED holdings, sector breakdown, or dividend history.

FMED can be compared against other funds using the overlap calculator or side-by-side comparison tool. FMED alternatives are available via the screener, along with tax-loss harvesting opportunities.